⌘K

Login Start Free

Home/Filings/4/0001127602-22-017895

4//SEC Filing

Burton Paul 4

Accession 0001127602-22-017895

CIK 0001682852other

View on SEC.gov Company Profile

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 4:03 PM ET

Size

12.0 KB

Accession

0001127602-22-017895

Insider Transaction Report

Form 4

Period: 2022-06-16

Moderna, Inc.MRNA

Chief Medical Officer

Transactions

Award
Restricted Stock Units
2022-06-16+3,663→ 3,663 total
Exercise: $0.00→ Common Stock (3,663 underlying)
Award
Stock Option (Right to Buy)
2022-06-16+6,902→ 6,902 total
Exercise: $121.08From: 2023-06-16Exp: 2032-06-16→ Common Stock (6,902 underlying)
Award
Restricted Stock Units
2022-06-16+10,990→ 10,990 total
Exercise: $0.00→ Common Stock (10,990 underlying)
Award
Stock Option (Right to Buy)
2022-06-16+19,772→ 19,772 total
Exercise: $121.08From: 2024-06-16Exp: 2032-06-16→ Common Stock (19,772 underlying)

Footnotes (4)

[F1]25% of this option will vest and become exercisable on June 16, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
[F2]25% of the shares subject to this restricted stock unit award will vest on June 16, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
[F3]50% of this option will vest and become exercisable on June 16, 2025 and the remaining 50% will vest and become exercisable on June 16, 2026, subject to the recipient's continued service.
[F4]50% of the shares subject to this restricted stock unit award will vest on June 16, 2025 and the remaining 50% will vest on June 16, 2026, subject to the recipient's continued service.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

Moderna, Inc.

CIK 0001682852

Entity typeother

Related Parties

1

filerCIK 0001869869

Filing Metadata

Form type: 4
Filed: Jun 20, 8:00 PM ET
Accepted: Jun 21, 4:03 PM ET
Size: 12.0 KB

View on SEC.gov